NattoPharma and TG Montgomery – leading direct sales agent of vitamin K2 in Norway - entering Sweden with MenaQ7®

NattoPharma and TG Montgomery, one of the largest sales agents of vitamin K2 in
Norway, have signed an agreement to enter the Swedish market with the brand
MenaQ7® - K2 vitamin.
TG Montgomery is one of NattoPharma's largest customers of the brand MenaQ7®. TG
Montgomery's pioneering marketing of vitamin K2 in Norway has the last two years
generated very good sales figures, and the company has built a Norwegian client
portfolio that buys MenaQ7® regularly through a subscription scheme.

TG Montgomery has chosen Sweden as their next focus country, a country with
twice as many inhabitants as Norway. In Sweden the knowledge of vitamin K2 is
growing but the availability of vitamin K2 small.

Throughout spring and summer 2015 TG Montgomery established a good
infrastructure for direct sales of MenaQ7® - K2 vitamin in Sweden, and starts up
a test sale of the product August 2015. The test sale is built up in the same
way as the successful marketing concept that was launched in Norway 2014. TG
Montgomery strongly believe in a market breakthrough for MenaQ7® - K2 vitamin in
Sweden, and expects shortly to get twice as many customers in Sweden that the
company currently has in Norway. As a part of the initiative TG Montgomery the
next two years plans to invest nearly 100 million NOK in a country-specific
marketing and product information of MenaQ7® - vitamin K2 in Sweden.

"The brand MenaQ7® in Norway has become synonymous with Vitamin K2", says CEO
Kim Øien in TG Montgomery. "We have good experiences with selling vitamin K2
delivered from NattoPharma in Norway, and has therefore chosen NattoPharma's
MenaQ7 - K2 vitamin for our efforts in Sweden. This is because MenaQ7® is the
only vitamin K2 product in the world that has patent protection for health
benefits, and is the only vitamin K2 with backing clinical documentation proving
that vitamin K2 has positive health effects in humans, "continues Øien."The
documented proven product MenaQ7® - K2 vitamin, combined with excellent customer
references, a good infrastructure, strong marketing concept and not least a
changing market - at an increased e-commerce trade - enables TG Montgomery to
look very optimistic for the future possibilities for MenaQ7® - Vitamin K2 in
Sweden ".

"The major initiative to TG Montgomery in Sweden for MenaQ7® is very good news
for us," says CEO of NattoPharma, Hogne Vik. "TG Montgomery has achieved
excellent sales results for our vitamin K2 in the Norwegian market. NattoPharma
expects that we'll see a similar market penetration - and consequently increased
sales of our vitamin K2, MenaQ7, in Sweden as a result of this initiative. The
fact that TG Montgomery will enter Sweden with a significant marketing campaign
is positive for NattoPharma, also considering the possibility that the trademark
MenaQ7 will be more familiar in Sweden and that the substance vitamin K2's
positive health benefits may be better known among the general public ",
continues Vik.

# # #

About MenaQ7®

MenaQ7® is the best documented, commercially available natural vitamin K2 with
guaranteed actives and stability, clinical substantiation and international
patents granted and pending. For more information on the health benefits of
MenaQ7, visit menaq7.com.

About NattoPharma

NattoPharma USA, Inc. is the wholly owned U.S. subsidiary of NattoPharma ASA,
Norway, which is the world’s leader in vitamin K2 research and development.
NattoPharma is the exclusive international supplier of MenaQ7®, the natural
vitamin K2 as MK-7, and the company has been in a multi-year research and
development program to substantiate and discover the health benefits of natural
vitamin K2 for applications in the marketplace for functional food and dietary
supplements. For more information, visit nattopharma.com.

For more information, please contact:

Hogne Vik, CEO NattoPharma

Cell phone: +47 97 53 53 26

E-mail: hogne.vik@nattopharma.com